/Stocks
NYSEOphthalmic Goods

Alcon Inc. ALC

Price

Full chart with drawing tools and indicators
Valuation and ratios (P/E, margins, market value)

Price charts and figures by TradingView, shown in a sealed box: it cannot read this page, but TradingView may count your visit. Prices can be delayed.

Results from SEC filings

Revenue$7.2B+10%FY ending Dec 31, 2010
Gross profit$5.7B+4%FY ending Dec 31, 2025
Operating income$2.5B+9%FY ending Dec 31, 2010
Net income$980.0M-4%FY ending Dec 31, 2025
Earnings per share$7.27+9%FY ending Dec 31, 2010
Research & development$990.0M+13%FY ending Dec 31, 2025
Cash from operations$2.4B-2%FY ending Dec 31, 2010
Capital spending$309.0M-10%FY ending Dec 31, 2010
Share buybacks$33.0M+371%FY ending Dec 31, 2010
Dividends paid$1.0B-1%FY ending Dec 31, 2010
Cash$2.5B-16%FY ending Dec 31, 2010
Long-term debt$0-100%FY ending Dec 31, 2010
Shareholders' equity$7.3B+23%FY ending Dec 31, 2010
Shares outstanding302M+1%FY ending Dec 31, 2010

Insider trades

No insider trades reported in the last 12 months.

Trades by members of Congress

3 members reported 0 buys and 3 sales since Mar 3, 2025. Amounts are legal ranges, not exact figures.

MemberTradeAmountTradedReportedOwner
Kevin Hern RSold$1,001–$15KAug 5, 2026Sep 1, 2026Self
Josh Gottheimer DSold$1,001–$15KMar 12, 2026Apr 8, 2026Joint
Julie Johnson DSold$1,001–$15KMar 3, 2025Apr 14, 2025Joint

Latest SEC filings

All filings on SEC EDGAR ↗

About Alcon Inc.

Business description
Industry
Ophthalmic Goods
Sector
Industrial Applications and Services
Headquarters
Fort Worth, TX
Incorporated in
Switzerland
Fiscal year ends
December 31
Exchange
NYSE
Filer size
Large accelerated filer
SEC company number (CIK)
1167379

Company figures and insider trades: U.S. Securities and Exchange Commission (EDGAR). Congress trades: Clerk of the U.S. House of Representatives. Nebula is not affiliated with either and this page is not investment advice.